A mobile wallet intervention to improve tuberculosis care in rural Uganda
My Mobile Wallet: An Intervention to Support Access to Tuberculosis Care and Medication Adherence in Rural Uganda
['FUNDING_OTHER'] · MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY · NIH-11094062
This study is testing a new mobile wallet program to help people in rural Uganda get better access to tuberculosis care and stick to their medication by using text reminders and money for transport, making it easier for them to stay healthy.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY (nih funded) |
| Locations | 1 site (MBARARA, UGANDA) |
| Trial ID | NIH-11094062 on ClinicalTrials.gov |
What this research studies
This research investigates a mobile wallet intervention designed to enhance access to tuberculosis (TB) care and improve medication adherence among patients in rural Uganda. By utilizing SMS reminders and mobile money for transport and incentives, the project aims to address financial and behavioral barriers that hinder TB treatment success. The intervention will be developed through user-centered approaches, including focus group discussions, to ensure it meets the needs of the target population. The goal is to create a sustainable model that can effectively support patients in adhering to their TB medication regimen.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who are diagnosed with tuberculosis and reside in rural Uganda.
Not a fit: Patients who are not diagnosed with tuberculosis or those living outside the targeted rural areas may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve TB treatment outcomes and reduce transmission rates in rural communities.
How similar studies have performed: Previous research has shown promise in using financial incentives and mobile technology to improve health outcomes, making this approach both innovative and grounded in successful methodologies.
Where this research is happening
MBARARA, UGANDA
- MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY — MBARARA, UGANDA (ACTIVE)
Researchers
- Principal investigator: MUSIIMENTA, ANGELLA — MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY
- Study coordinator: MUSIIMENTA, ANGELLA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus